BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 19115209)

  • 1. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis.
    De Vuyst H; Clifford GM; Nascimento MC; Madeleine MM; Franceschi S
    Int J Cancer; 2009 Apr; 124(7):1626-36. PubMed ID: 19115209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study.
    Bertoli HK; Thomsen LT; Iftner T; Dehlendorff C; Kjær SK
    Gynecol Oncol; 2020 May; 157(2):456-462. PubMed ID: 32008794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors.
    Smith JS; Backes DM; Hoots BE; Kurman RJ; Pimenta JM
    Obstet Gynecol; 2009 Apr; 113(4):917-924. PubMed ID: 19305339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
    Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
    Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
    Lindquist S; Frederiksen K; Petersen LK; Kjær SK
    Int J Cancer; 2024 Jul; 155(1):61-70. PubMed ID: 38418719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer.
    Hampl M; Sarajuuri H; Wentzensen N; Bender HG; Kueppers V
    Obstet Gynecol; 2006 Dec; 108(6):1361-8. PubMed ID: 17138767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status.
    Mpunga T; Chantal Umulisa M; Tenet V; Rugwizangoga B; Milner DA; Munyanshongore C; Heideman DAM; Bleeker MCG; Tommasino M; Franceschi S; Baussano I; Gheit T; Sayinzoga F; Clifford GM
    Int J Cancer; 2020 Mar; 146(6):1514-1522. PubMed ID: 31173641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva.
    Faber MT; Sand FL; Albieri V; Norrild B; Kjaer SK; Verdoodt F
    Int J Cancer; 2017 Sep; 141(6):1161-1169. PubMed ID: 28577297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN).
    Srodon M; Stoler MH; Baber GB; Kurman RJ
    Am J Surg Pathol; 2006 Dec; 30(12):1513-8. PubMed ID: 17122506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM
    Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.
    Insinga RP; Liaw KL; Johnson LG; Madeleine MM
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1611-22. PubMed ID: 18628412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.
    Nygård M; Hansen BT; Dillner J; Munk C; Oddsson K; Tryggvadottir L; Hortlund M; Liaw KL; Dasbach EJ; Kjær SK
    PLoS One; 2014; 9(2):e88323. PubMed ID: 24505474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus.
    Jamieson DJ; Paramsothy P; Cu-Uvin S; Duerr A;
    Obstet Gynecol; 2006 May; 107(5):1023-8. PubMed ID: 16648406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.
    Stier EA; Sebring MC; Mendez AE; Ba FS; Trimble DD; Chiao EY
    Am J Obstet Gynecol; 2015 Sep; 213(3):278-309. PubMed ID: 25797230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus.
    van Beurden M; ten Kate FJ; Smits HL; Berkhout RJ; de Craen AJ; van der Vange N; Lammes FB; ter Schegget J
    Cancer; 1995 Jun; 75(12):2879-84. PubMed ID: 7773937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.
    Alemany L; Saunier M; Alvarado-Cabrero I; Quirós B; Salmeron J; Shin HR; Pirog EC; Guimerà N; Hernandez-Suarez G; Felix A; Clavero O; Lloveras B; Kasamatsu E; Goodman MT; Hernandez BY; Laco J; Tinoco L; Geraets DT; Lynch CF; Mandys V; Poljak M; Jach R; Verge J; Clavel C; Ndiaye C; Klaustermeier J; Cubilla A; Castellsagué X; Bravo IG; Pawlita M; Quint WG; Muñoz N; Bosch FX; de Sanjosé S;
    Int J Cancer; 2015 Jan; 136(1):98-107. PubMed ID: 24817381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade vulvar and vaginal intraepithelial neoplasia: correlation of histologic features with human papillomavirus DNA detection and MIB-1 immunostaining.
    Logani S; Lu D; Quint WG; Ellenson LH; Pirog EC
    Mod Pathol; 2003 Aug; 16(8):735-41. PubMed ID: 12920216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana.
    Rantshabeng PS; Moyo S; Moraka NO; Ndlovu A; MacLeod IJ; Gaseitsiwe S; Kasvosve I
    BMC Infect Dis; 2017 Nov; 17(1):731. PubMed ID: 29178840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of human papillomavirus-associated cancers among persons with AIDS.
    Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
    J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.